Abstract:At present, numerous novel chemical compounds face challenges related to their limited solubility in aqueous environments. These compounds are classified under the Biopharmaceutical Classification System (BCS) as either class II or class IV substances. Different carriers were used to increase their solubility. Candesartan cilexetil (CC) is one of the most widely used antihypertensive drugs, which belongs to class II drugs. The aim of this research was to enhance the solubility and dissolution rate of CC through a complexation approach involving β-cyclodextrin and its derivatives, specifically hydroxypropyl beta cyclodextrin (HP-β-CD), methyl beta cyclodextrin (M-β-CD), and sulfonyl ether beta-cyclodextrin (SBE-β-CD), serving as complexing agents. This complexation process was investigated both with and without the inclusion of poloxamer 407 (PX407) as a hydrophilic polymer. The complex was prepared through a combination of grinding, kneading, and co-evaporation techniques. The resulting complex underwent characterization, including assessments of its percentage yield, drug content, solubility, and dissolution properties, as well as analyses using differential scanning calorimetry (DSC), X-ray diffraction (XRD), and fourier transforms infrared spectroscopy (FTIR). The results revealed that, the complex prepared using 1:1 molar ratio of M -β-CD:CC in the presence of 5% w/w PX407 by co-evaporation method had the highest percentage yield (97%) with drug content of 98.5%, the highest solubility (0.052 mg/mL) and fastest release of drug within 45 minutes compared to the other methods. The FTIR, DSC, and XRD confirmed the development of a partial inclusion complex of an amorphous nature

Synthesis method of candesartan cilexetil

New Technique for Synthesis of Cilastatin

Improved Synthesis of 1-[Hexahydrocyclopenta[c]pyrrol-2(1h)-yl]-3-(4-methylbenzenesulfonyl)ure A

Study on the Industryial Production of Citalopram

An Improved Synthesis Of A Beta-Blocker Celiprolol Hydrochloride

Efficient Synthesis of Valsartan, A Nonpeptide Angiotensin Ii Receptor Antagonist

Commercial Synthesis of Azilsartan Kamedoxomil: An Angiotensin II Receptor Blocker

Synthesis and Chiral Resolution of 2,2- Dimethylcyclopropane Carboxylic Acid

The Organic Process Research of Valsartan

Summary of Synthesis Methods of Olmesartan Medoxomil and Key Intermediates

Highly Efficient and Practical Synthesis of the Key Intermediate of Telmisartan

Solubility and Dissolution Enhancement of Candesartan Cilexetil by Complexation with Cyclodextrin

New Synthesis Process for the Synthesis of Ezetimibe

Multistep synthesis of a valsartan precursor in continuous flow

Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo

An alternative synthesis of Azilsartan: an angiotensin II receptor blocker

Determination of Candesartan Concentration in Human Plasma by HPLC-Fluorometric Method and Bioequivalence of Candesartan Cilexetil Preparations

Determination of candesartan cilexetil in candesartan cilexetil tablets by HPLC

Polymorphic and Quantum Chemistry Characterization of Candesartan Cilexetil: Importance for the Correct Drug Classification According to Biopharmaceutics Classification System

Synthesis of a Sacubitril Precursor Via the Construction of One-Pot Chemoenzymatic Cascades

Application of Negishi Coupling Reaction in the Synthesis of Biphenyl Group in Sartans